Ono Pharmaceutical Co., Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ono Pharmaceutical Co., Ltd. generated cash of $110,660,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$89,848,000,000 last year. Net change in cash is therefore $70,006,000,000.
Cash Flow
| 2015 | 31.57B | -12.75B | -19.60B |
|---|---|---|---|
| 2016 | 12.84B | 13.03B | -19.46B |
| 2017 | 74.45B | -17.98B | -20.55B |
| 2018 | 15.72B | -34.18B | -62.54B |
| 2019 | 66.77B | -49.76B | -22.27B |
| 2020 | 74.15B | -10.23B | -54.72B |
| 2021 | 73.97B | -57.58B | -24.75B |
| 2022 | 61.82B | 6.03B | -60.23B |
| 2023 | 159.61B | -100.25B | -32.48B |
| 2024 | 110.66B | 48.07B | -89.84B |
OPHLF Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 96.13B | 69.11B | 61.04B | 69.00B | 59.98B | 65.27B | 146.32B | 110.48B | 104.22B | 104.89B |
Operating activities | ||||||||||
Net income | 127.97B | 143.53B | 105.02B | 100.89B | 79.69B | 65.14B | 63.92B | 74.54B | 33.27B | 18.30B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 18.14B | 17.45B | 17.72B | 15.82B | 14.21B | 10.62B | 9.21B | 7.82B | 6.53B | 6.1B |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -19.78B | -14.51B | -15.28B | -7.17B | -793M | 1.25B | 0 | -11.19B | 0 | 282M |
Inventories | -3.42B | -2.94B | -2.46B | -6.10B | -173M | -1.56B | -5.97B | -2.04B | 2.56B | -1.54B |
Accounts payable | -1.83B | 13.09B | 8.17B | 6.36B | 1.99B | 998M | 0 | 4.98B | 0 | 0 |
Cash generated by operating activities | 110.66B | 159.61B | 61.82B | 73.97B | 74.15B | 66.77B | 15.72B | 74.45B | 12.84B | 31.57B |
Investing activities | ||||||||||
Purchases Of Investments | -36.73B | -140.59B | -58.61B | -81.69B | -45.8B | -56.67B | -30.86B | -24.04B | -863M | -3.67B |
Investments In Property Plant And Equipment | -4.02B | -14.49B | -12.27B | -20.29B | -22.44B | -29.60B | -29.83B | -24.07B | -14.08B | -31.11B |
Acquisitions Net | 0 | -9.15B | -6.76B | -13.27B | -14.54B | -7.28B | -9.55B | -9B | -6.12B | -13.57B |
Cash generated by investing activities | 48.07B | -100.25B | 6.03B | -57.58B | -10.23B | -49.76B | -34.18B | -17.98B | 13.03B | -12.75B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8M | 0 |
Payments for dividends | -37.18B | -29.74B | -27.66B | -22.44B | -22.77B | -21.82B | -23.41B | -20.11B | -19.05B | -19.06B |
Repurchases of common stock | -50.01B | -1M | -30.00B | -3M | -29.58B | -1M | -38.77B | -22M | -49M | -33M |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -361M | -417M | -398M | -366M | -487M |
Cash used in financing activities | -89.84B | -32.48B | -60.23B | -24.75B | -54.72B | -22.27B | -62.54B | -20.55B | -19.46B | -19.60B |
Net Change In Cash | 70.00B | 27.02B | 8.06B | -7.96B | 9.02B | -5.29B | -81.05B | 35.83B | 6.26B | -676M |
Cash at end of period | 166.14B | 96.13B | 69.11B | 61.04B | 69.00B | 59.98B | 65.27B | 146.32B | 110.48B | 104.22B |